Ramon Lleonart
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Sebetralstat for on-demand treatment of hereditary angioedema: A pooled analysis of placebo-controlled clinical trials.
Journal: The World Allergy Organization journal
Published: December 22, 2025
Oral deucrictibant for on-demand treatment of hereditary angioedema attacks (RAPIDe-1): a randomised, double-blind, placebo-controlled, phase 2 trial.
Journal: The Lancet. Haematology
Published: August 25, 2025
Oxaliplatin-induced type II hypersensitivity in colorectal cancer: a cohort study on clinical presentation, diagnosis, and management.
Journal: Frontiers in pharmacology
Published: April 03, 2025
Global frequency, diagnosis, and treatment of hereditary angioedema with normal C1 inhibitor.
Journal: The journal of allergy and clinical immunology. Global
Published: September 19, 2024
Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks.
Journal: The New England journal of medicine
Published: May 31, 2024
A Core Outcome Set for Efficacy of Acute Treatment of Hereditary Angioedema.
Journal: The journal of allergy and clinical immunology. In practice
Published: January 17, 2024
Definition, acronyms, nomenclature, and classification of angioedema (DANCE): AAAAI, ACAAI, ACARE, and APAAACI DANCE consensus.
Journal: The Journal of allergy and clinical immunology
Published: November 28, 2023
Selection of initiatives to improve the management of patients with hereditary angioedema by the hospital pharmacy using the nominal group technique.
Journal: European journal of hospital pharmacy : science and practice
Published: November 20, 2023
Exceptional treatment of COVID-19 pneumonia with icatibant.
Journal: Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias
Published: March 11, 2022
Effectiveness and safety of a microcrystalline tyrosine-adjuvanted Dermatophagoides pteronyssinus allergoid immunotherapy in adult patients with allergic asthma and rhinitis: A real-life prospective observational study.
Journal: Immunity, inflammation and disease
Published: September 16, 2021
A multicenter, open-label, randomized, proof-of-concept phase II clinical trial to assess the efficacy and safety of icatibant in patients infected with SARS-CoV-2 (COVID-19) and admitted to hospital units without invasive mechanical ventilation: study protocol (ICAT-COVID).
Journal: Trials
Published: August 10, 2021
Hereditary angioedema due to C1 inhibitor deficiency: real-world experience from the Icatibant Outcome Survey in Spain.
Journal: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
Published: June 01, 2021
Last Updated: 09/26/2026